MoonLake Immunotherapeutics Class A Ordinary Shares Share Price
NASDAQ: MLTX | Small CapMoonLake Immunotherapeutics Class A Ordinary Shares Stock Performance
Open $17.50 | Prev. Close $18.27 | Circuit Range N/A |
Day Range $16.55 - $17.59 | Year Range $5.95 - $62.69 | Volume 1,55,020 |
Average Traded $17.13 |
MoonLake Immunotherapeutics Class A Ordinary Shares Share Price Today
As of 11 August 2026, MoonLake Immunotherapeutics Class A Ordinary Shares's share price is $17.35. The stock opened at $17.50, compared to its previous close of $18.27. During today's trading session, MoonLake Immunotherapeutics Class A Ordinary Shares's share price traded between $16.55 and $17.59, with an average price of $17.07. Over the past 52 weeks, the stock has recorded a high of $62.69 and a low of $5.95. In terms of performance, MoonLake Immunotherapeutics Class A Ordinary Shares's share price has declined by 0.97% over the last six months and is down 68.86% on a year-on-year basis.
MoonLake Immunotherapeutics Class A Ordinary Shares Share Price Chart
MoonLake Immunotherapeutics Class A Ordinary Shares Stock Fundamentals & Key Indicators
Market Cap $1.12B | PE Ratio (TTM) -4.92 | Dividend Yield N/A |
EPS (TTM) $-3.53 | Revenue (TTM) N/A | Return On Equity (TTM) -75.64% |
Profit Margin N/A | Debt to Equity 0.15 | Quarterly Earnings Growth YoY -97.03% |
MoonLake Immunotherapeutics Class A Ordinary Shares Quarterly Profit & Loss
All figures in USD
MoonLake Immunotherapeutics Class A Ordinary Shares Annual Profit & Loss
All figures in USD
About MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
MoonLake Immunotherapeutics Class A Ordinary Shares Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $18.37 | $17.36 | -5.88% |
Jul 2026 | $19.75 | $18.45 | -5.26% |
Jun 2026 | $18.91 | $19.47 | +1.54% |
May 2026 | $16.37 | $19.18 | +17.35% |
Apr 2026 | $17.29 | $16.34 | -12.29% |
Mar 2026 | $17.29 | $18.63 | +6.34% |
Feb 2026 | $16.35 | $17.52 | +11.84% |
Jan 2026 | $13.19 | $15.66 | +18.99% |
Dec 2025 | $13.59 | $13.16 | -4.25% |
Nov 2025 | $10.37 | $13.75 | +36.54% |
Oct 2025 | $6.93 | $10.07 | +40.45% |
Sep 2025 | $55.58 | $7.17 | -87.13% |
MLTX Share Price FAQs
What is MoonLake Immunotherapeutics Class A Ordinary Shares share price today?
What is the 52 week high and 52 week low of MoonLake Immunotherapeutics Class A Ordinary Shares stock?
What is MLTX's market capitalisation today?
What is MLTX's net income for the last quarter?
What is the 5 year returns of MLTX?
What is the high & low stock price of MLTX today?
Can I buy MLTX shares in India?